Background illustration for clinical trials search

Paid Clinical Trials Oregon

Discover 1,086 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Scaleable Video Coaching Intervention for Opioid-using Mothers

for
Child Behavior, Parent-Child Relations, Substance Use,
Location: Eugene OR
Sponsor: University of Oregon

Sex: All

Age: 0 - 50

Code: NCT04749771

Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Brewer ME, Burlington MA, Manchester NH, Worcester MA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

for
Relapsed Hematologic Malignancy,
Location: Boston MA, New York NY, Durham NC, Buffalo NY,
Sponsor: Curis, Inc.

Sex: All

Age: 18+

Code: NCT03328078

Phase 1, Phase 2, Recruiting

Clinical Procedures to Support Research in ALS

for
Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia,
Location: Durham NC, Miami FL, Winston-Salem NC, Minneapolis MN,
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT03489278

Recruiting

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

for
Aortic Dissection, Aortic Aneurysm, Intramural Hematoma,
Location: Hartford CT, New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Endospan Ltd.

Sex: All

Age: 18+

Code: NCT04471909

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Beat Childhood Cancer Specimen Banking and Data Registry

for
Pediatric Cancer, Survivorship
Location: Hartford CT, Norfolk VA, Hershey PA, Miami FL,
Sponsor: Giselle Sholler

Sex: All

Age: 0+

Code: NCT04715178

Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Westbrook ME, Mississauga, Brampton, Jacksonville FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06170788

Phase 3, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

Shift Worker Intervention for Sleep Health

for
Shift Work Type Circadian Rhythm Sleep Disorder,
Location: Corvallis OR
Sponsor: Oregon State University

Sex: All

Age: 18 - 65

Code: NCT06384742

Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

for
Small Cell Lung Cancer Extensive Stage
Location: Fairfax VA, Canton OH, Cincinnati OH, Fairfield OH,
Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT05703971

Phase 1, Phase 2, Recruiting

Observational Study of Corneal Opacities in Adults

for
Corneal Opacities (Scar and Stromal Dystrophy)
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT02109471

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Burlington MA, The Bronx NY, New Brunswick NJ,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701656

Phase 2, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Boston MA, Lebanon NH, New York NY, New Brunswick NJ,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase 1, Recruiting

Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

for
Obstructive Sleep Apnea, Down Syndrome
Location: Norfolk VA, Ann Arbor MI, Houston TX, Dallas TX,
Sponsor: Oregon Health and Science University

Sex: All

Age: 2 - 17

Code: NCT05508971

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

for
Respiratory Tract Diseases, Influenza (Pandemic), Influenza,
Location: Quebec, Sherbrooke, New York NY, Montreal, Ottawa,
Sponsor: UMC Utrecht

Sex: All

Age: 0+

Code: NCT02735707

Phase 3, Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase 3, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for
Idiopathic Pulmonary Fibrosis
Location: Farmington CT, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals

Sex: All

Age: 40+

Code: NCT05571059

Phase 2, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Popular cities in Oregon